Prospera Financial Services Inc Immunovant, Inc. Transaction History

Prospera Financial Services Inc

  • $3.82 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022
BUY
$3.93 - $6.37 $42,353 - $68,649
10,777 New
10,777 $60,000
Q2 2022

Aug 08, 2022
SELL
$3.38 - $5.65 $30,876 - $51,612
-9,135 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$5.06 - $8.77 $46,223 - $80,113
9,135 New
9,135 $50,000
Q4 2020

Feb 12, 2021
SELL
$36.36 - $52.71 $44,940 - $65,149
-1,236 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$22.61 - $38.9 $27,945 - $48,080
1,236 New
1,236 $43,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email